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Figure 1. Total bone marrow and weighted bone marrow 
dosimetry (presented are averages and 95% confidence 
intervals). 
 
Conclusion: With the use of the novel techniques such as p-
CSI and BM-HT quality of life impairing acute side effects 
such as cytopenias and dysphagia can be reduced. We 
propose WBME to better assess the impact on active bone 
marrow. 
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Purpose or Objective: Whole lung irradiation (WLI) of 12 to 
18 Gy is used as treatment for lung metastases in patients 
with Ewing sarcoma and Wilms tumour. This results in 
irradiation of normal tissues including heart and breast. 
Conventionally this treatment has been delivered with 
standard AP-PA fields. To minimise cardiac radiation dose 
and reduce the risk of subsequent late complications, we 
validated the use of VMAT to deliver WLI without increasing 
the predicted risks of secondary breast cancers compared to 
AP-PA fields. 
 
Material and Methods: Five female patient datasets (ages 
ranging from 3 to 18 years) were used for this retrospective 
study. The planning target volume (PTV) included total lung 
volume with a 1 cm margin (and adjacent vertebrae for three 
patients). Organs at risks included were heart, breast 
bud/tissue, liver and thyroid. 6 MV AP-PA (with segments) 
and RapidArc (2 or 3 full arcs) plans were created using the 
Eclipse treatment planning system (Version 11). Plans were 
calculated using the anisotropic analytical algorithm (AAA). 
The prescribed dose was either 15 Gy in 10 fractions or 18 Gy 
in 12 fractions based on the patient’s age. PTV D2%, D98% 
and D50% and mean and maximum doses for heart and breast 
were obtained. The absolute excess risk (AER) of cardiac 
mortality at 15 years post treatment was calculated for each 
plan based on an age-at-exposure adjusted relative risk per 
Gy obtained from published data (1,2,3,4) combined with 
contemporary UK population-based absolute risks. The risk of 
breast cancer induction was calculated using the model 
proposed by Schneider et al. (2011) (5). 
 
Results: The VMAT plans resulted in a similar minimum PTV 
coverage when compared to the AP-PA plans whilst reducing 
the PTV D2% by an average of 6.1% (4.1 – 9.1). The use of 
VMAT reduced the heart and breast mean dose by an average 
of 19.1% (11.7 – 30.5) and 16.2% (-2.2 – 30.4) respectively 
when compared to the AP-PA plans. The difference in AER of 
cardiac mortality at 15 years was lower for the VMAT plans by 
an average of 0.48% (0.11 – 0.98). The average excess 
absolute risk (EAR) for breast cancer induction across all 
plans decreased by 2.9% (-0.8 – 6.8) when compared to the 
conformal plans (assuming α/β = 3 Gy, α = 0.067 Gy-1, R = 
0.62, µ = 4.8/10000PY/Gy). 
 
 
Conclusion: VMAT achieved highly conformal plans and 
reduced cardiac late normal tissue complication probability 
whilst also reducing (or achieving similar) predicted risk of 
second cancer induction in breast tissue. 
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Purpose or Objective: Traditionally, patients with rectal 
cancer (T2 anterior low rectum, T3-T4 N0-N+) are treated 
with preoperative radiotherapy or chemoradiation (CAP 50 
regimen). 3D Conformal Radiation Therapy is conventionally 
delivered: 44 Gy more 6 Gy as a sequential boost to the high 
risk target volume (total dose 50 Gy). Another strategy would 
be to use the Contact Therapy technique [1] using 50 kV X-
rays (CXRT) to deliver higher dose (30 Gy) to the high risk 
target volume in addition to 44 Gy. The present study first 
describes CXRT dose computation with Monte-Carlo 
simulations and then compares the resulting dose 
(EBRT+CXRT) with the conventional treatment (EBRT only). 
 
Material and Methods: The CXRT machine Papillon 50™ 
installed in Centre Antoine Lacassagne (Nice, France) delivers 
a 50 kV X-ray beam with a dose rate close to 15 Gy/min, 
allowing treatment delivery more comfortable for the 
patients [2]. The system is currently used for treating skin 
and rectal cancers. The detailed geometry of the Papillon 
50™ machine [3] was fully generated in Monte-Carlo code 
PenEasy based on PENELOPE [4] and the resulting simulations 
were validated against measurements in water (depth dose 
curves and transverse dose profiles) for all applicators used 
for rectum cancer. For 10 patients with T2-T3 nodes smaller 
than 3 cm, dose distributions were calculated to irradiate the 
high risk target volume. For each patient, 30 Gy CXRT dose 
was computed with Monte-Carlo simulation in 3DCT patient 
data acquired in a position close to the rectal cancer CXRT 
position (genupectoral position). 6 Gy EBRT treatment was 
computed with the commercial TPS Isogray (Dosisoft) in the 
3DCT scan acquired in supine position. Both dose 
distributions were compared in terms of dosimetric indices 
computed for target volumes (conformity and homogeneity 
indices) and dose to organs at risk. 
 
Results: Monte-Carlo penEasy simulations are in good 
agreement with the Papillon50TM measurements in water for 
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all rectum applicators. Simulations in patients 3DCT scan 
allowed us to evaluate CXRT dose to organs at risk and to the 
target volume. The comparison of dosimetric indices of EBRT 
and CXRT treatment delivery for the high risk target volume 
showed that the CXRT technique delivers higher dose to the 
target volume for the same dose, or even less for some cases, 
to the organs at risk. 
 
Conclusion: Monte-Carlo simulations are useful to compute 
accurate dose distributions in 3DCT patient data for the CXRT 
treatment delivery. Moreover, this comparative study 
between the EBRT and CXRT techniques confirms the role of 
CXRT in curative treatment with organ preservation for early 
rectal cancers. 
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Purpose or Objective: In previous studies the dosimetric 
impact of an implanted rectum spacer (IRS) in prostate 
cancer patients undergoing intensity-modulated radiation 
therapy (IMRT) has been assessed by dose-volume histograms 
(DVHs) and dose-surface histograms (DSHs) obtained from 3D 
dose distributions of the ano-rectal wall (ARW). 
Unfortunately, spatial information is lost when analyzing 
DVHs or DSHs. This hampers to study the correlation between 
the shape and location of the ARW dose distribution and 
clinical outcome. Dose-surface maps (DSMs) have been 
suggested as a valuable tool for taking the spatial-dosimetric 
information into account.The purpose of this study is to 
assess spatio-dosimetric differences in DSMs obtained from 
planned ARW dose distributions in patients receiving IMRT 
with and without IRS (IMRT+IRS; IMRT-IRS, respectively). 
 
Material and Methods: In 26 patients with localized prostate 
cancer a hydrogel rectum spacer (SpaceOAR®, Augmenix) was 
injected under transrectal ultrasound guidance in 
Denonvilliers’ space between the prostate and the rectal 
wall. Per patient, two IMRT treatment plans (78 Gy in 39 
fractions) were designed, based on CT scans acquired before 
and after hydrogel injection. DSMs of the ARW were 
generated from the planned 3D dose distributions by virtual 
unfolding the rectum contour as described in Buettner et al. 
(Fig. 1a-b).  
 
 
Various shape-based dose measures were extracted from the 
DSMs. First, dose clusters were generated by thresholding the 
DSMs at 38 dose levels ranging from 5-79 Gy. Then, for each 
dose level an ellipse was fitted to the largest dose cluster. 
Lateral (posterior-anterior-posterior) and longitudinal 
(superior-inferior) extents were quantified by projecting the 
major and minor axes of this ellipse to the main axes of the 
DSMs. The non-circularity of the dose clusters was described 
by the eccentricity of the ellipse. The contiguity of the ARW 
dose distribution was assessed by the contiguous-DSH (cDSH), 
reflecting the single largest contiguous ARW area fraction as 
function of the dose threshold at the given level. Statistical 
differences were assessed with a one-sided paired Wilcoxon 
signed rank test. 
 
Results: Lateral extent, longitudinal extent as well as cDSH 
were significantly lower in IMRT+IRS than for IMRT-IRS at 
high-dose levels. Largest significant differences were 
observed for cDSH at dose levels >50Gy, followed by lateral 
extent at doses >57Gy, and longitudinal extent. For these 
three features, no significant differences were observed for 
low to medium dose levels. For eccentricity no significant 
differences were found, independent of the dose level. 
 
Conclusion: Significant spatio-dosimetric differences in ARW 
DSMs exist between prostate cancer patients undergoing IMRT 
with and without IRS. The IRS particularly reduces the lateral 
and longitudinal extent of high-dose areas (>50 Gy) in 
anterior and superior-inferior directions. 
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Purpose or Objective: SBRT is a novel treatment procedure, 
which is used for the particular localization of the tumor to 
deliver targeted high doses with greatly precise fields. 
Different irradiation techniques provide a wide spectrum of 
therapy options. The aim of this work was to evaluate the 
clinical benefits and potential dosimetric of different 
planning methods against each other for the treatment of 
NSCLC. 
 
Material and Methods: In this study, three diagnosed 
patients with NSCLC metastasis, were chosen. One had a 
peripheral metastasis in the left lung , the other had a 
metastasis in the right lung, and the last one had a central 
metastasis located near to vertebral body. The delineated 
structures (PTV and OARs) on CT were shared among 22 
clinics with the request to generate an irradiation plan with 
their own internal criteria. Three fractions of 15 Gy were 
prescribed to the PTV-enclosing 65%. All together it was 
